Indian Retail Investors' Preference for Dollar Exposure Reveals Shift in Investment Habits

India's Hidden Dollar Dilemma: A Silent Threat to Retail Portfolios

India's retail investors, numbering over 22 crore as of March 2026, are largely unaware of a significant threat to their portfolios. A large share of their investments is structurally exposed to the US dollar, US interest rate decisions, and US equity valuations. This exposure arises through three channels, none of which explicitly labels itself as a currency bet.

The Direct Route: Remittances and Dollar Exposure

In the 11 months from April 2025 to February 2026, outward remittances under the Reserve Bank of India's Liberalised Remittance Scheme (LRS) stood at $26.38 billion, a slight decline from the $27.01 billion in the same period the previous year. However, the investment component of these remittances is on the rise. Remittances for equity and debt rose 53% year-on-year in February 2026 alone to $265.99 million. This exposure is visible, as investors know they hold US stocks.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The Indirect Route: Domestic Mutual Funds

The less visible exposure sits inside domestic mutual fund platforms. Fund of Funds (FoF) schemes investing overseas held a combined Assets Under Management (AUM) of Rs 38,287 crore as of March 2026, a 53% increase from Rs 25,031 crore in March 2025. These schemes often carry names like US Opportunities Fund or Global Innovation Fund and are presented to retail investors as a portfolio benefit. However, the rupee-dollar risk is not disclosed on the platform interface.

The Embedded Route: Dollar-Denominated Revenue Streams

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Indian companies like Infosys, Aurobindo Pharma, and Dr. Reddy's derive a significant portion of their revenue from the US. An investor holding an IT index fund or a pharma ETF holds a dollar-denominated revenue stream. When the rupee depreciates, these companies report higher rupee revenues, and when the dollar weakens, or US pricing pressure intensifies, rupee earnings compress.

The Portfolio-Level Problem

A typical retail portfolio built over the last four years contains an IT large-cap or index fund, a pharma fund or stock picked during the Covid rally, one or two US-linked FoF or ETF schemes added for diversification, and possibly a direct US equity position through an LRS-enabled broker. No single line item signals danger, but together, a substantial share of that portfolio's returns moves with the dollar and with US Federal Reserve rate decisions.

Old-Era Disclosure Framework

SEBI's current disclosure requirements address each instrument separately, but no regulation requires an aggregated currency exposure disclosure at the portfolio level. No platform is required to show a retail investor their combined dollar weight across domestic stocks, feeder funds, and direct LRS holdings.

The Number Nobody Has Calculated

SEBI tracks retail investor participation, RBI monitors LRS outflows, and AMFI reports overseas fund AUM, but no regulator combines these data sets with listed company revenue geography disclosures to produce a household-level dollar exposure estimate. That number does not exist in any published form.

India's equity markets have long moved with US Federal Reserve decisions and dollar flows, and that sensitivity now runs directly through retail household portfolios, not only through FPI flows. In 2025, it already did. The tariff shock, FII selling, and US rate uncertainty hit IT stocks, pharma counters, and overseas feeder funds simultaneously. The 22 crore demat account holders who believed they were invested in Indian equities absorbed losses driven by events in Washington and on Wall Street.

Most retail investors holding Indian pharma stocks, IT index funds, and US-linked feeder schemes are already dollar-long. The institutional investor was told this in the last earnings call. The retail investor has not been told at all.